These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ. Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [Abstract] [Full Text] [Related]
45. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge. Keser H, Barnes M, Moes G, Lee HS, Tıhan T. Turk Patoloji Derg; 2014 Jun; 30(1):23-9. PubMed ID: 24448703 [Abstract] [Full Text] [Related]
47. A clinicopathological study of 323 patients with oligodendrogliomas. Ludwig CL, Smith MT, Godfrey AD, Armbrustmacher VW. Ann Neurol; 1986 Jan; 19(1):15-21. PubMed ID: 3947035 [Abstract] [Full Text] [Related]
48. High angiogenic potential in an in vivo rat corneal model is associated with shorter disease-free survival in low-grade oligodendrogliomas. Ozkan A, Guduk M, Atabay KD, Uyar SB, Seker A, Konya D, Pamir MN, Kilic T. J Clin Neurosci; 2011 Jan; 18(1):109-13. PubMed ID: 20943394 [Abstract] [Full Text] [Related]
52. The role of postoperative irradiation in the treatment of oligodendroglioma. Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS. Int J Radiat Oncol Biol Phys; 1994 Oct 15; 30(3):567-73. PubMed ID: 7928487 [Abstract] [Full Text] [Related]